In women with PCOS who are not overweight, higher levels of the hormone leptin are linked to higher levels of free testosterone and lower levels of the protein that binds testosterone, indicating a possible connection between fat-related hormones and male hormone activity.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could determine whether leptin levels consistently correlate with androgen markers across studies in non-obese PCOS women.
A systematic review and meta-analysis of all studies measuring serum leptin and FAI/SHBG in non-obese PCOS women, adjusting for BMI, insulin resistance, and age, to quantify the strength and consistency of these associations.
An RCT could determine whether lowering leptin levels (e.g., via weight loss or pharmacologic intervention) reduces androgen levels in non-obese PCOS women.
A double-blind, randomized, placebo-controlled trial of 60 non-obese PCOS women assigned to a leptin-sensitizing agent (e.g., metformin or GLP-1 agonist) or placebo for 24 weeks, measuring serum leptin, FAI, and SHBG as primary endpoints, while controlling for diet and activity.
A prospective cohort could determine whether baseline leptin levels predict future changes in FAI or SHBG in non-obese PCOS women.
A 2-year prospective cohort study of 150 non-obese PCOS women with annual measurements of serum leptin, FAI, and SHBG, adjusting for weight change, insulin resistance, and dietary intake, to assess whether leptin predicts androgen changes.
A case-control study could compare leptin levels in non-obese PCOS women with high vs. low androgen levels to identify hormonal profiles.
A case-control study comparing 40 non-obese PCOS women with FAI >8 (high androgen) to 40 with FAI <4 (low androgen), matched for BMI and age, measuring fasting serum leptin and SHBG, adjusting for insulin resistance.
A cross-sectional study could replicate the association between leptin and androgen markers in a larger sample of non-obese PCOS women.
A cross-sectional study measuring serum leptin, FAI, and SHBG in 250 non-obese women with PCOS across multiple centers, stratified by ethnicity and insulin sensitivity, to validate the observed correlations.